![](https://d3ilqtpdwi981i.cloudfront.net/7jW0KooyAT0C0ikz6fCjpueCbqQ=/0x38:371x518/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/96/38/64/9638649d-91a4-4419-9a71-ee784e999d94/BHSF%20Pineapple%20Logo%20%28Imported%20Works%29.png)
Article
Eribulin Plus Pembrolizumab in Patients With Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase 1b/2 Study
Clinical Cancer Research
Publication Date
6-1-2021
Content Type
application/pdf
PubMed ID:
33727258
Citation Information
Clinical Cancer Research (2021) 27(11):3061-3068.